Convention Name Individuals
Steven Seedhouse – Cantor Fitzgerald & Co., Analysis Division
Ryan Deschner – Raymond James & Associates, Inc., Analysis Division
Michael Ulz – Morgan Stanley, Analysis Division
Hardik Parikh – JPMorgan Chase & Co, Analysis Division
Biren Amin – Piper Sandler & Co., Analysis Division
Tsan-Yu Hsieh – William Blair & Firm L.L.C., Analysis Division
Annabel Samimy – Stifel, Nicolaus & Firm, Included, Analysis Division
Jay Olson – Oppenheimer & Co. Inc., Analysis Division
Yale Jen – Laidlaw & Firm (UK) Ltd., Analysis Division
Fiona Shang – Jefferies LLC, Analysis Division
William Wooden – B. Riley Securities, Inc., Analysis Division
Jeet Mukherjee – BTIG, LLC, Analysis Division
Gregory Renza – Truist Securities, Inc., Analysis Division
Daniel Brims – Lake Avenue Capital Markets, LLC, Analysis Division
Presentation
Operator
Good day, and welcome to the Viking Therapeutics Second Quarter 2026 Monetary Outcomes Convention Name. [Operator Instructions] And as a reminder, this convention name is being recorded right now, July 29, 2026. I might now like to show the convention over to Viking’s Supervisor of Investor Relations, Stephanie Diaz. Please go forward, Stephanie.
Stephanie Diaz
Good day, and thanks all for taking part in right now’s name. Becoming a member of me right now is Brian Lian, Viking’s President and CEO; and Greg Zante, Viking’s CFO. Earlier than we start, I might prefer to warning that feedback made throughout this convention name right now, July 29, 2026, will comprise forward-looking statements underneath the protected harbor provisions of the U.S. Personal Securities Litigation Reform Act of 1995, together with statements about Viking’s expectations concerning its improvement actions, time strains and milestones.
Ahead-looking statements are topic to dangers and uncertainties that might trigger precise outcomes to vary materially and adversely, and reported outcomes shouldn’t be
